Authors:Mao Jia-Jun, Chen Yu-De, Zhang Gui-Rong, and Zhou Zu-Ming
A study on the synergistic extraction of uranium(VI) from nitric acid media with double-chelating agent systems 1-phenyl-3-methyl-4-benzoyl-pyrazolone-5 (PMBP) plus thenoyltrifluoroacetone (TTA), and 1-phenyl-3-methyl-4-benzoyl-pyrazolone-5 plus 1-phenyl-3-methyl-4-trifluoroacetyl-pyrazolone-5 (PMTFP) is described. Some synergistic effects have been observed. The experimental results suggest that the composition of synergistic complex species is UO2PMBP·TTA and UO2PMBP·PMTFP, respectively. The equilibrium constants for these synergistic extractions are calculated by three methods and the mechanism and the regularity of extraction are discussed as well.
Authors:Yong He, Rui Ding, Hang Liu, Xiao Wang, Jing-Li Xu, Man Feng, Yu-Rong Chen, Chuan-Min Qi, Cheng Peng, Zhao-Hui Zhu, Yong-Hong Dang, Ming Wang, and Yun-Chuan Ma
As degradation product of Antineoplaston A10 in vivo, phenylacetyl glutamine showed antitumor activities. According to literatures,
we designed and radiosynthesized a phenylacetyl glutamine derivative, which was achieved under a mild reaction condition.
Evaluations in vitro and in vivo were performed on tumor bearing mice. Excitingly, the radiochemical purity of (S)-2-((S)-2-(4-(3-fluoropropyl)benzamido)-3-phenylpropanamido)pentanedioic
acid ([18F]FBPPA) was 98%, and besides the best radiochemical yield was up to 46%. T/Bl (Tumor/Blood) and T/M (Tumor/Muscle) ratios
of [18F]FBPPA at 60 min post injection were 2.33 and 3.51. Meanwhile, it showed satisfied stability in vitro and in vivo, compared
with 2-[18F]fluorodeoxyglucose ([18F]FDG). Although [18F]FBPPA deserved further studies to make optimizations on its structure, the results revealed it might become a potential
PET imaging agent for detecting tumors.
Authors:Chuan-Min Qi, Yong He, Xiao Wang, Man Feng, Jing-Li Xu, Rui Ding, Hang Liu, Yu-Rong Chen, Fang Li, Zhao-Hui Zhu, Yong-Hong Dang, Shu-Ting Zhang, and Ying Xie
d-glucosamine at concentration of certain range could kill tumor cells without influencing normal cells. There are also some
reports on the antitumor activity of d-glucosamine and its derivatives in murine models. It was therefore postulated that d-glucosamine might have the potential to invade tumor cells. We designed and radiosynthesized a glucosamine derivative, N-(2-[18F]fluoro-4-nitrobenzoyl)glucosamine ([18F]FNBG([18F]7)). Evaluations in vitro and in vivo were performed on tumor bearing mice. Excitingly, the radiochemical purity of [18F]FNBG([18F]7) was 99%, and besides the best radiochemical yield was up to 35%. The best T/Bl (Tumor/Blood) and T/M (Tumor/Muscle) ratios
of [18F]FNBG([18F]7) were 4.40 and 4.84. Although [18F]FNBG([18F]7) deserved further studies, the results revealed it might become a potential PET imaging agent for detecting tumors.